AgBiome Announces EPA Approval of Theia Fungicide
June 5, 2022 AgBiome, Inc., a leader in developing innovative products from the Earth’s microbial communities, has announced that their newest product, Theia fungicide, has received approval from the EPA. Theia fungicide, developed through AgBiome’s GENESIS platform, is the second proprietary AgBiome crop protection product to be marketed.
“Today, we are one step closer to bringing growers of high-value crops yet another extremely effective disease management tool,” said Dr. Toni Bucci, chief operating officer for AgBiome. “This registration and impending commercial launch are proof of AgBiome’s ability to fulfill our promise of innovating to enhance the global agricultural ecosystem.”
Theia fungicide delivers broad-spectrum foliar and soil disease control through multiple modes of action, including fungicidal and bactericidal metabolites, and is OMRI Listed. With excellent control on diseases such as powdery mildew and Fusarium that have the power to devastate high-value fruit and vegetable crops, Theia fungicide is poised to become an important disease control solution for growers.
Howler fungicide, launched in 2019, is a highly effective tool against a broad-spectrum of soilborne and foliar diseases. Theia fungicide complements Howler fungicide with distinct modes of action and the ability to perform against additional key disease targets.
“Theia fungicide is a testament of our platform’s unique ability to identify the best fungicidal strains for growers using our proprietary tools,” said Dr. Brooke Bissinger, Theia fungicide product manager for AgBiome. “From the microbe discovery by our own plant pathologist Dr. Phil Hammer, to the final steps toward commercialization today, we’re proud to see this approval granted for this product from our GENESIS platform.”
State registrations are now pending and growers can expect Theia fungicide to be available for purchase through AgBiome’s retail partners later this year.
Subscribe Today For
